HCW Biologics Inc. (HCWB) vs Mobile-health Network Solutions Class A Ordinary Shares (MNDR)

A side-by-side comparison of HCW Biologics Inc. and Mobile-health Network Solutions Class A Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
HCW Biologics Inc. logo
HCWB
HCW Biologics Inc.
$563178
$1.62HealthcareDelayed quote: Oct 6, 2026, 12:42 PM EDT
Mobile-health Network Solutions Class A Ordinary Shares logo
MNDR
Mobile-health Network Solutions Class A Ordinary Shares
$30509
$1.24HealthcareDelayed quote: Oct 6, 2026, 12:34 PM EDT

Total return — HCWB vs MNDR

growth of $100 · dividends reinvested · last 2y
HCWB -99.6% (-93.3%/yr)MNDR -100.0% (-98.8%/yr)HCWB compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020252026$0$0
HCWB MNDR

HCWB vs MNDR: by the numbers

  • •HCWB is the larger company ($563178 vs $30509 market cap).
  • •Both run net losses; MNDR's is the smaller (-44.25% vs -73.22% net margin).

Metrics side by side

Valuation

MetricHCWBMNDR
P/S ratio0.08N/A
P/B ratio0.080.00

Profitability

MetricHCWBMNDR
Gross margin20.00%-11.45%
Operating margin-20757.65%-46.36%
Net margin-73.22%-44.25%
ROE-66.26%-124.31%
ROIC-41.92%-116.42%

Growth (annualized)

MetricHCWBMNDR
Revenue CAGR (5Y)-57.90%N/A
Total return CAGR (5Y)-69.71%N/A

Go deeper

Full HCWB analysisFull MNDR analysisInteractive comparison tool

Dig into the metrics

HCW Biologics ROEMobile-health Network Solutions Class A Ordinary Shares ROEHCW Biologics operating marginMobile-health Network Solutions Class A Ordinary Shares operating marginHCW Biologics revenue growthMobile-health Network Solutions Class A Ordinary Shares revenue growthHCW Biologics free cash flowMobile-health Network Solutions Class A Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.